Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
NCT00374140
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Small Cell Lung Cancer
Interventions
DRUG:
RAD001 (everolimus)
Sponsor
Ahmad Tarhini
Collaborators
[object Object]